Introduction {#Sec1}
============

The olfactory bulb is the first relay station of the olfactory system in the brain. Here, olfactory receptor neurons (ORN) are synaptically connected to interneurons and to mitral and tufted cells that project to higher cortical areas. The synapses between ORNs, interneurons, and mitral/tufted cells are localized to spherical neuropil structures - the glomeruli. Glomeruli are surrounded by a heterogeneous population of neurons that, by morphological criteria, fall into three classes: periglomerular (PG) cells, short axon (SA) cells, and external tufted (ET) cells (Kosaka et al. [@CR33]; Pinching and Powell [@CR53]). Collectively, these cells have been termed juxtaglomerular cells. Immunohistochemical studies suggest that juxtaglomerular cells can be grouped into many subpopulations (Kosaka et al. [@CR33]). However, the entire repertoire of juxtaglomerular cells, their specific function, and their electrophysiological properties are largely unknown.

Juxtaglomerular cells form connections within and between glomeruli, providing the basis for the processing of odor information. Within glomeruli, ORNs provide excitatory input to PG, ET, and mitral/tufted cells. PG cells form inhibitory synapses with ORNs, ET, and mitral/tufted cells, whereas ET cells are excitatory to PG cells (for a detailed review of different circuits within glomeruli, see Wachowiak and Shipley [@CR64]). Connections between glomeruli involve ET, PG, and SA cells (Pinching and Powell [@CR54]). A prominent, yet controversial, model of an interglomerular circuit describes a network for the so-called center-surround inhibition (Aungst et al. [@CR4]; Kosaka et al. [@CR34]). In this model, SA cells receive excitatory input from ET cells and, in turn, excite PG cells that are up to 30 glomeruli away. These PG cells inhibit mitral/tufted cells. Thereby, the activity of ORNs through the successive activation of ET, SA, and PG cells finally inhibits the mitral/tufted cells of neighboring glomeruli.

Rhythmic electrical activity that is either intrinsic or produced by odors is essential for olfactory information processing (Adrian [@CR1]; Fletcher et al. [@CR22]; Hayar et al. [@CR25], [@CR26]; Macrides and Chorover [@CR40]; Margrie and Schaefer [@CR43]; Nusser et al. [@CR49]; Stopfer and Laurent [@CR61]; Walsh [@CR65]). In heart and brain, hyperpolarization-activated and cyclic-nucleotide-gated (HCN) ion channels control synchronized network activity (Bender et al. [@CR9]; Luthi and McCormick [@CR39]; Bal and McCormick [@CR7]), oscillations (Lüthi and McCormick [@CR38]; Ludwig et al. [@CR37]; Stieber et al. [@CR59]), and temporal integration of synaptic activity in dendrites (Magee [@CR41]; Magee and Carruth [@CR42]; Angelo et al. [@CR2]). HCN channels may also sustain rhythmic activity in the olfactory bulb (Liu and Shipley [@CR35]). The four HCN channel isoforms (HCN1--HCN4) differ in their activation kinetics and modulation by cAMP (Kaupp and Seifert [@CR28]; Stieber et al. [@CR60]). The physiological role of HCN channels depends on their density and subcellular localization (Berger et al. [@CR10]; Day et al. [@CR19]; Magee [@CR41]; Magee and Carruth [@CR42]). Moreover, the heteromerization of HCN channel isoforms has been proposed as a mechanism to enhance functional diversity. Although HCN channels, when heterologously expressed, form heteromers (Chen et al. [@CR17]; Much et al. [@CR45]; Ulens and Tytgat [@CR62]), little is known about the existence and functional significance of heteromers in native tissue (Whitaker et al. [@CR67]).

In situ hybridization and initial immunohistochemical studies suggest strong expression of all four HCN channel isoforms in the olfactory bulb of mouse and rat (Notomi and Shigemoto [@CR48]; Santoro et al. [@CR58]; Holderith et al. [@CR27]). However, neither the expression of HCN isoforms at the single-cell level, nor any patterns of co-expression have been analyzed in depth. We have examined the distribution of all four HCN channel isoforms in the glomerular layer of mouse by using specific antibodies. We have observed abundant expression of all four HCN isoforms. HCN channels are present in most populations of juxtaglomerular cells identified by commonly used marker antibodies. Several of these cell populations express two or three HCN isoforms. Our results support the notion of a large variety of juxtaglomerular cell populations and provide the basis for a better understanding of rhythmic electrical activity in the olfactory bulb.

Materials and methods {#Sec2}
=====================

Animals {#Sec3}
-------

Adult mice (C57BL/6N\@Rj; Elevage Janvier France) were used. All procedures were approved by the local animal care committee.

Antibodies against HCN channels {#Sec4}
-------------------------------

Antibody production has been described elsewhere (Mataruga et al. [@CR44]; Müller et al. [@CR46]). In brief, for the rat monoclonal antibodies RTQ-7C3, QQA-1A6, and TLL-6C5, peptides used to produce antibodies consisted of seven N-terminal amino acids (aa; CGSSHHH), followed by 35 aa specific for a given HCN channel isoform (RTQ-7C3: aa sequence 650--685 of rat HCN1; QQA-1A6: aa sequence 699--734 of human HCN2; TLL-6C5: aa sequence 640--675 of rat HCN3). The guinea pig polyclonal antibodies HCN4γ and HCN2β, the rat monoclonal antibody PG2-1A4 (HCN4), and the rabbit polyclonal antibodies HCN2α and HCN3α4 were obtained after immunization with a glutathione S-transferase fusion protein: the HCN2 fusion protein contained mouse HCN2 aa sequence 798--863, the HCN3 fusion protein contained mouse HCN3 aa sequence 718--779, and the HCN4 fusion protein contained mouse HCN4 aa sequence 1116--1201. For generation of the guinea pig polyclonal antibody HCN1α, a keyhole limpet hemocyanin fusion protein containing aa sequence 1--18 of mouse HCN1 was used. We chose antigenic sequences of mouse HCN channels similar to those used by Notomi and Shigemoto ([@CR48]) for the generation of HCN2α, HCN2β, HCN3α4, HCN4γ, and PG2-1A4 antibodies. Immunization of rabbits and guinea pigs (Pineda Antibody Service, Berlin, Germany; Peptide Specialty Laboratories, Heidelberg, Germany) and the generation of monoclonal antibodies (E. Kremmer, Institute for Molecular Immunology, Helmholtz Zentrum, Munich, Germany) were performed according to standard procedures. To minimize cross-reactivity, HCN2α, HCN2β, and HCN3α4 were purified by affinity chromatography with a fusion protein of the HCN channel sequences used for immunization and the maltose-binding protein coupled to cyan-bromide-activated Sepharose 4B (Amersham Pharmacia Biotech, Freiburg, Germany).

SDS-polyacrylamide gel electrophoresis and Western blot analysis {#Sec5}
----------------------------------------------------------------

Isolation of membranes and cytosolic proteins of the olfactory bulb of mouse, SDS-polyacrylamide gel electrophoresis (SDS-PAGE), and Western blot analysis were performed as described by Müller et al. ([@CR46]). Proteins (12 μg per lane) were separated on a 10% SDS-polyacrylamide gel and electrotransferred onto a polyvinylidene difluoride filter. Primary antibodies were RTQ-7C3 (HCN1), HCN2α, HCN3, and HCN4γ (dilutions: 1:3, 1:1000, 1:6000, and 1:400, respectively). Secondary antibodies conjugated to horseradish peroxidase were: goat anti-rat IgG (for RTQ-7C3; 1:5000; Jackson ImmunoResearch Laboratories, West Grove, USA), goat anti-rabbit IgG (for HCN2α and HCN3; 1:5000; Amersham, Ilford, England), and goat anti-guinea pig IgG (for HCN4γ; 1:5000; Santa Cruz Biotechnology, Santa Cruz, USA).

Immunohistochemistry {#Sec6}
--------------------

Mice (*n*=13; ∼2 months old) were fixed by intracardial perfusion of ice-cooled 0.9% NaCl solution followed by 4% paraformaldehyde (PFA) and 15% saturated picric acid in 0.15 M phosphate buffer (PB). Brains were removed, postfixed for 0.5 h, rinsed with PB, and incubated in 10% sucrose in PB with 0.05% NaN~3~ for 1 h, followed by 30% sucrose in PB with 0.05% NaN~3~ for 48 h. Olfactory bulbs were embedded and frozen in OCT compound. Coronal sections (20 μm thick) were cut on a cryostat and collected on Superfrost Plus slides (Menzel, Braunschweig, Germany). Only glomeruli at the medial aspect of sections through the middle part of the olfactory bulb were analyzed.

Sections were preincubated for 1 h in 5% chemiblocker (Chemicon International, Temecula, USA), 0.5% Triton X-100, and 0.05% NaN~3~ in PB, followed by incubation overnight with primary antibodies diluted in the same solution. Sections were washed in PB and incubated in secondary antibodies diluted in 5% chemiblocker with 0.5% Triton X-100 in PB for 1 h, washed in PB, and cover-slipped with Aqua Polymount (Polysciences Europe, Eppelheim, Germany). Primary antibodies were as described in Table [1](#Tab1){ref-type="table"}. Secondary antibodies were donkey anti-guinea pig Cy2 (1:400), donkey anti-guinea pig Cy3 (1:800), donkey anti-guinea pig Cy5 (1:800), goat anti-mouse Alexa488 (1:500), donkey anti-mouse Cy3 (1:100), donkey anti-mouse Cy5 (1:100), goat anti-rabbit Alexa488 (1:500), donkey anti-rabbit Cy3 (1:500), donkey anti-rabbit Cy5 (1:100), goat anti-rabbit Alexa488 (1:500), and donkey anti-rat Cy3 (1:500). Donkey antibodies were purchased from Dianova (Hamburg, Germany) and goat antibodies from Molecular Probes (Invitrogen, Karlsruhe, Germany). For double- or triple-labeling, primary antibodies generated in different species were mixed and applied simultaneously. All secondary antibodies were highly cross-absorbed and were tested to exclude reactions with the wrong primary antibody. Table 1Primary antibodies. If no source is stated, cyclic-nucleotide-gated (*HCN*) antibodies were generated as described in [Materials and methods](#Sec2){ref-type="sec"}Target proteinAnti-bodySpeciesDilutionCharacterizationImmunizing antigen/sourceReferencesHCN1HCN1aloRabbit polyclonal1:400Western blot, immunohistochemistry; results identical to independent antibodyRat HCN1 aa6--24/polyclonal rabbit anti-HCN1, Alomone, Jerusalem, Israel, prod. no. APC-056, LOT AN-08Muller et al. ([@CR46])RTQ-7C3Rat monoclonal1:3 to 1:5Western blot, immunohistochemistry; results identical to independent antibodyRat HCN1 aa650--685/in houseMuller er al. ([@CR46])HCN1αGuinea pig polyclonal1:300Western blot, immunohistochemistry; results identical to independent antibodyMouse HCN1 aa1--18/in houseMataruga et al. ([@CR44])HCN2HCN2αRabbit polyclonal1:500Western blot, immunohistochemistry; results identical to independent antibodyMouse HCN2 aa798--863/in house-HCN2βGuinea pig polyclonal1:500Western blot, immunohistochemistry; results identical to independent antibodyMouse HCN2 aa798--863/in house-QQA-1A6Rat monoclonal1:3Western blot, immunohistochemistry; results identical to independent antibodyHuman HCN2 aa699--734/in house-HCN3HCN3 ShigemotoRabbit polyclonal1:700Western blot, immunohistochemistry; results identical to independent antibodyMouse HCN3 aa718-stop, R. Shigemoto, National Institute for Physiology, Myodaiji, Okazaki, Japan-TLL-6C5Rat monoclonal1:1Western blot, immunohistochemistry; results identical to independent antibodyRat HCN3 aa640--675/in houseMuller et al. ([@CR46])HCN3α4Rabbit polyclonal1:1800Western blot, immunohistochemistry; results identical to independent antibodyMouse HCN3 aa718-stop/in house-HCN4HCN4γGuinea pig polyclonal1:2000Western blot, immunohistochemistry; results identical to independent antibodyMouse HCN4 aa1116-stop/in houseMataruga et al. ([@CR44])PG2-1A4Rat monoclonal1:10Western blot, immunohistochemistry; results identical to independent antibodyMouse HCN4 aa1116-stop/in houseMataruga et al. ([@CR44])HCN4aloRabbit polyclonal1:500Western blot, immunohistochemistry; results identical to independent antibodyHuman HCN4 aa119--155/anti-HCN4, Alomone, Jerusalem, Israel, prod. no. APC-052, LOT AN02Feigenspan et al. ([@CR21])Tyrosine hydroxylase (TH)THMouse monoclonal1:500 to 1:1000Imunoblot, immunoprecipitation, immuno-histochemistry; result similar to TH (Neuromics) and virtually identical to Baker et al. [@CR6], Parrish-Aungst et al. ([@CR51])Purified rat TH/anti-TH, Sigma, Saint Louis, USA, prod. no. T2928, LOT 105H4830-THchChicken polyclonal1:500Western blot, immunocytochemistry, immunohistochemistry; result similar to TH (Sigma) and virtually identical to Baker et al. ([@CR6]), Parrish-Aungst et al. ([@CR51])Peptide corresponds to region of TH shared between mouse and human/anti-TH, Neuromics, Edina, USA, cat. no. CH23006, LOT 400563-Cholecystokinin (CCK)CCKMouse monoclonal1:5000Immunohistochemistry; result virtually identical to, e.g., Gutierrez-Mecinas et al. ([@CR24]), Kosaka and Kosaka ([@CR30], [@CR31])Gastrine/CCK/anti-CCK, antibody no. 9303, CURE, Digestive Diseases Research Center, Antibody/RIA CoreGutierrez-Mecinas et al. ([@CR24])Nitric oxide synthase (NOS)NOSmonoMouse monoclonal1:500Western blot, immunofluorescence, immunohistochemistry; results similar to NOSpoly (Sigma) and NOSgt (Everest Biotech) and virtually identical to Kosaka and Kosaka ([@CR30], [@CR31]),C-terminal aa sequence 1095--1289 of human neuronal NOS/anti-neuronal NOS (nNOS), Transduction Laboratories, Lexington, USA, cat. no. N31020, LOT7-NOSpolyRabbit polyclonal1:4000Immunoblot; results similar to NOSmono (Transduction Laboratories) and NOSgt (Everest Biotech) and virtually identical to Kosaka and Kosaka ([@CR30], [@CR31]),C-terminal peptide K-RSESIAFIEESKKDADEVFSS/anti-NOS, brain (bNOS), 1409--1429, Sigma, Saint Louis, USA, prod. no. N7280, LOT 47H4813-NOSgtGoat polyclonal1:500Western blot; results similar to NOSmono (Transduction Laboratories) and NOSpoly (Sigma) and virtually identical to Kosaka and Kosaka ([@CR30], [@CR31]),C-terminal aa sequence C-ESKKDTDEVFSS/anti-NOS 1(neuronal), Everest Biotech, Upper Heyford, UK, prod. no. EB05259-Parvalbumin (PV)PVRabbit polyclonal1:2000Imunoblot, radioimmunoassay, immunohistochemistry; result virtually identical to Kosaka et al. ([@CR32]), Crespo et al. ([@CR18]), Brinon et al. ([@CR14])Purified rat muscle PV/anti-PV, swant, Bellinzona, Switzerland,cCat. no. PV-28, LOT 5.5-Calbindin-D-28k (CB)CabPneuMouse1:1000Immunoblot, immunohistochemistry; no cross-reactivity with other members of the EF hand family; result virtually identical to Brinon et al. ([@CR13]), Bastianelli and Pochet ([@CR8]), Crespo et al. ([@CR18])Purified bovine kidney CB/anti-CB, Sigma, Saint Louis, USA, prod. no. C9848, clone CB-955-Visinin-like protein-1 (neurocalcin α; vilip1)vilip1Rabbit polyclonal1:1000Western blot, immunohistochemistry; result virtually identical to, e.g., Bastianelli and Pochet ([@CR8]), Crespo et al. ([@CR18]), Brinon et al. ([@CR15])Purified recombinant His-tagged visinin-like protein-1 fusion protein/Braunewell K-H, Biochemistry & Molecular Biology Department, Southern Research Institute, Birmingham, USABernstein et al. ([@CR11]), Gierke et al. ([@CR23])Hippocalcin (hippo)hippoRabbit polyclonal1:1000Western blot, immunohistochemistryPurified recombinant His-tagged hippo fusion protein/Braunewell K-H, see aboveBernstein et al. ([@CR11])Calretinin (CR)CALRabbit polyclonal1:10,000Immunohistochemistry; immunoblot assay against other calcium-binding proteins; results similar to CALgt (Chemicon) and virtually identical to Bastianelli and Pochet ([@CR8]), Crespo et al. ([@CR18]), Brinon et al. ([@CR14])Purified recombinant human CR/anti-CR, swant, Bellinzona, Switzerland, prod. no. 7699/4, LOT 18299Bouilleret et al. ([@CR12])CALgtGoat polyclonal1:3000Western blot, immunohistochemistry; result similar to CAL (swant) and virtually identical to Bastianelli and Pochet ([@CR8]), Crespo et al. ([@CR18]), Brinon et al. ([@CR14])Purified guinea pig CR/anti-CR, Chemicon International, cat. no. AB1550, LOT 20010336-Glial fibrillary acidic protein (GFAP)GFAPabRabbit polyclonal1:2000Immunofluorescence, immunohistochemistry; result identical to GFAP (Sigma) and virtually identical to Bailey and Shipley ([@CR5])Purified bovine spinal cord GFAP/anti-GFAP, Abcam, Cambridge, UK, prod. no. ab 7779--500, LOT 240312-GFAPMouse monoclonal1:400Immunofluorescence, immunohistochemistry, no cross-reactivity with vimentin; result identical to GFAPabcam (Abcam) and virtually identical to Bailey and Shipley ([@CR5])Purified pig spinal cord GFAP/anti-GFAP, Sigma, Saint Louis, USA, prod. no. G3893, Clone G-A-5, LOT 44H4819-

In some experiments, staining was performed with two antibodies generated in the same species. This was possible only if the two antibodies stained different cell compartments, e.g., the soma membrane and the cytosol. Two cases could be distinguished. (1) Antibodies stained different compartments in different cells. In this case, the two antibodies were detected with the same secondary antibody. Staining, whereby each primary antibody was applied alone, were used as a reference to distinguish between the staining of the two antibodies. (2) Antibodies stained different compartments in the same cell. In this case, staining patterns were distinguished by using a technique described by Vardi et al. ([@CR63]). This technique involved the use of Fab fragments to block one of the antibodies produced in the same species. Here, we used the technique only for some staining with HCN3 antibodies. In brief, sections were incubated with rabbit anti-HCN3 overnight, washed in PB, incubated with goat anti-rabbit Fab fragments conjugated to Cy3 (1:1000; Dianova, Hamburg, Germany) for 1 h, washed in PB, incubated with a rabbit anti-marker antibody (twice as concentrated as given in Table [1](#Tab1){ref-type="table"}) for 1 h, washed in PB, and finally incubated with donkey anti-rabbit Cy5 or goat anti-rabbit Alexa488 as described above. Control experiments in which anti-marker antibodies were omitted displayed no Cy5 or Alexa488 staining. Furthermore, stringent internal controls were included in each staining; the strong staining resulting from one primary antibody was not detected by the secondary antibody used for the other primary antibody. In addition, all staining of a primary antibody was similar, irrespective of whether it had been used alone or in combination with another primary antibody raised in the same species.

Sections were examined with a Leica TCS confocal laser scanning microscope (LSM, Leica Microsystems Germany) with 20×/0.7 and 63×/1.32 oil immersion lenses. The contrast and brightness of the images were optimized in Adobe Photoshop. Laser intensity and filter settings were carefully controlled, and the sequential scanning mode was employed to rule out cross-talk between the fluorescence detection channels completely. Band pass filters of 500--530 nm for green fluorescence (Alexa488, Cy2), 580--650 nm for red fluorescence (Cy3), and 680--750 nm for infra-red fluorescence (Cy5) were used.

Cells were classified as PG-, SA-, or ET-like by several independent expert observers. The observers classified large numbers of cells comprising all 17 different immunohistochemical fingerprints (IFs) on z-stacks (examples of reconstructed cells are shown below and in the [Electronic Supplementary Material](#AppESM1){ref-type="sec"}) or by visual inspection of staining at the microscope. PG-, SA-, and ET-like cells were identified on the basis of morphological criteria. PG cells are neurons with small somata and usually one or two dendrites that ramify extensively in a single (sometimes two) neighboring glomeruli. In contrast, SA cells are larger than most PG cells. Often, SA cells have more than two dendrites that do not ramify in glomeruli but rather reach across several adjacent glomeruli to contact other juxtaglomerular cells. ET cells display large somata and usually possess one thick primary tuft that ramifies within a single glomerulus. Some ET cells additionally possess far-reaching lateral dendrites (Pinching and Powell [@CR53]). Only cells that could clearly be classified by these criteria are shown in the figures and have been included in the analyses summarized in Tables [2](#Tab2){ref-type="table"}, [3](#Tab3){ref-type="table"} (excluding frequency of cell types, see below). We did not use criteria other than the presence/absence of thick primary tufts and presence/absence of HCN and marker stainings to establish IFs (see [Electronic Supplementary Material](#AppESM1){ref-type="sec"}). Table 2Immunohistochemical fingerprints (*IF*) in juxtaglomerular cells. IF1--IF9 (*arrowheads*) are found in PG-like cells, IF10 and IF11 (*barred arrows*) are found in SA-like cells, and IF12--IF17 (*arrows*) are found in ET-like cells (*+* to *++++* level of staining intensity, *+/-* weak staining detected in some cells of the respective cell population probably reflecting expression at the detection threshold, - no detected staining, *M* the indicated protein usually found within the cytosol but antibody staining appeared as plasma membrane staining in cells with IF1). Color and arrow code applies to figures, including those in the [Electronic Supplementary Material](#AppESM1){ref-type="sec"}Target proteinIF1IF2IF3IF4IF5IF6IF7IF8IF9IF10IF11IF12IF13IF14IF15IF16IF17ArrowheadsBarred arrowsArrowsGreenDark bluePinkOrangeRedLight blueBlackGrayWhiteGreenBlueWhitePurpleBrownLilacBlueGrayTH\-\-\-\-\-\-\--+ to ++++^a^\-\-\-\-\--+ to ++++^a^+ to ++++^a^CCK\--+ to ++^a^+ to ++^a^\-\-\-\-\-\--+ to ++^a^+ to ++^a^+ to ++^a^+ to ++^a^\--NOS+++\-\-\-\-\--+ to +++^a^-+++-+ to ++^a^+ to ++^a^+/\--+-vilip1+-++++++\-\-\-- to +^a^\-\--+/\--+ to +++^a^\-\--hippo+/- M\-\--++ to +++^a^++ to +++^a^\-\-- to ++^a^\-\-\--++- to ++^a^+ to ++^a^PV\-\-\-\-\-\-\-\-\-\-\--^b^-^b^-^b^-^b^-^b^-^b^CR\-\-\-\-\-\--++ to +++^a^-++ to +++^a^\-\-\--^b^-^b^-^b^-^b^-^b^-^b^CB\-\-\--+++++\-\--+/-+/\--^b^-^b^-^b^-^b^-^b^-^b^HCN1+++-+/-+/-+\-\-\--+/\--+ to ++^a^+/-+ to ++^a^\-\--HCN2+/\--+/\-\-\-\-\-\-\--+++\-\-\-\-\--HCN3\--++\-\-\-\--++-+ to ++^a^++ to ++^a^++/\--HCN4-+ to ++^a^\--++\--+/-+-+ to ++^a^+ to ++^a^-+ to ++^a^+/-+/-^a^Range of variable staining^b^Not analyzed in detail, usually no or very weak stainingTable 3Properties of cells with a particular immunohistochemical fingerprint (*PG* periglomerular cells, *SA* short axon cells, *ET* external tufted cells, *n.d.* not determined)Immunohistochemical fingerprint (IF)Diameter^a^ (μm)Number of cells per glomerulus section^a^Number of cells per glomerulus^a^Number of dendrites (for PG+SA) or presence of stained lateral dendrites (for ET)IF17.1±0.62.1±0.328.9±5.11IF27.8±1.02.0±0.125.0±3.31IF39.1±0.70.7±0.47.2±3.3≥2IF48.6±0.81.2±0.113.4±1.9≥2IF58.0±0.71.0±0.312.6±4.11^b^IF67.8±0.91.4±0.317.4±4.71^b^IF76.5±0.84.3±0.366.3±9.51^b^IF86.5±0.94.3±1.166.3±19.51^b^IF97.7±1.22.3±0.429.5±6.8n.d.IF109.4±1.10.4±0.14.0±0.5≥2IF118.9±0.70.4±0.14.7±0.9≥3IF1212.1±1.80.7±0.56.0±3.8YesIF1312.3±2.10.5±0.24.0±2.1YesIF1411.6±2.00.9±0.37.8±2.7NoIF1512.2±1.80.6±0.14.8±0.9YesIF1612.6±1.90.3±0.12.1±0.5NoIF1712.0±1.40.9±0.37.4±2.7NoTOPRO (nuclear stain)6.6±1.146.5±4.5705±136-^a^Mean±SD^b^In rare cases, 2

Measurement of somata size and frequency of cell types {#Sec7}
------------------------------------------------------

To quantify cell size, we measured the circumference of cells in confocal sections and calculated cell diameters by assuming a circular shape. In confocal sections, almost spherical cells can be cut at levels other than that yielding the maximal cell diameter. To avoid an under-estimation of the cell size, many somata of identified cells were analyzed, and only the largest third was used for the calculation of soma size. For frequent cell populations (cells with IF1, IF2, IF6, IF7, IF8, or IF9), we measured the circumferences of 40--61 individual cells, and for rare cell types (cells with IF3, IF4, IF5, IF10, IF11, IF12, IF13, IF14, IF15, IF16, or IF17), we measured the circumferences of 31--45 individual cells (*n*≥three animals each). Numbers are given as means±SD. This method allows the analysis of large amounts of data sets, albeit with considerable error. To demonstrate that, for the present study, the error was within a tolerable range, we reconstructed cells in three dimensions (3D; Imaris software, Bitplane, Zürich, Switzerland, see [Electronic Supplementary Material](#AppESM1){ref-type="sec"}) and calculated cell diameters as described above. We reconstructed 10 CB-stained and 10 CR-stained PG-like cells and calculated mean diameters of 7.9±0.4 μm and 6.7±0.5 μm, respectively. Using circumferences of the largest third, we calculated, for the CB and CR cell population, mean diameters of 7.9±0.8 μm and 6.5±0.8 μm, respectively. We also reconstructed ET-like cells (six NOS-stained and seven vilip1-stained cells) and calculated mean diameters of 11.5±0.6 μm and 10.8±0.4 μm, respectively (compared with 12.2±2 μm and 11.6±2 μm by using the circumferences of the largest third, respectively). Thus, both methods yielded similar results.

To estimate the frequencies at which different populations of juxtaglomerular cells occurred per glomerulus, we counted cells of a particular population in the neighborhood of many adjacent glomeruli in several confocal sections (*n*≥three animals per cell type, see Electronic Supplementary Material, Table [1](#MOESM1){ref-type=""}). Staining used to count the various populations were (for antibodies see Table [1](#Tab1){ref-type="table"}) HCN1/NOS (IF1), HCN1/HCN4/CB (IF1, IF2, IF5, and IF6), PV (IF4), TH/CAL/NOS (IF7, IF8, IF9, IF16, and IF17), NOS (IF10), HCN2 (IF11), HCN1/HCN4/NOS (IF12 and IF13), vilip1 (IF14), HCN1/CCK/NOS, and HCN4/NOS/TH (IF15). To estimate the frequency of cells with IF3, we counted all vilip1-positive PG-like cells and subtracted the number of PV-positive (IF4) cells.

The counting relied on four assumptions. (1) Somata and glomeruli are spherical. (2) All planes of a glomerulus are equally represented provided a sufficient number of confocal sections are analyzed. (3) All cells of a particular population can be readily identified in a confocal section; this assumption is expected not to be met completely, because the diameter of some cells in a confocal section will be too small and, therefore, frequencies will be underestimated. (4) All glomeruli contain similar proportions of cell populations. Ideally, the number of a given cell type per glomerulus, the frequency, can be determined by counting all cells of this type along an entire glomerulus in an extremely thick section. We derived the frequencies according to: $$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ {\text{Frequency}} = \frac{{{{\text{d}}_{\text{glom}}}C}}{{{{\text{d}}_{\text{celltype}}}{{\text{n}}_{\text{glom}}}}} $$\end{document}$$Cells of a given type were counted (number of counted cells = C) in confocal sections across many adjacent glomeruli (number of glomeruli = *n*~*glom*~) and expressed as cell numbers per section and glomerulus (*C/n*~*glom*~). To derive the frequency per whole glomerulus, *C/n*~*glom*~ was multiplied with the frequency that this cell type can be found along the Z-axis of a glomerulus. This measure can be expressed as *d*~*glom*~/*d*~*celltype*~, the ratio of the diameter of a standard glomerulus (*d*~*glom*~=100 μm; see Royet et al. [@CR57]) and the mean diameter of the cell soma (*d*~*celltype*~). To demonstrate the general applicability of the method, we determined the total cell number surrounding a standard glomerulus with a nuclear stain (TOPRO-3, Molecular Probes) and compared the result with published numbers established by the optical dissector method (Parrish-Aungst et al. [@CR51]).

Statistical analysis was performed with Microsoft Excel and Mathlab. Similarity between the soma diameters of the different cell populations was analyzed by using a pair-wise Kruskal-Wallis test with all possible combinations.

Results {#Sec8}
=======

Distribution of HCN channel isoforms in the olfactory bulb {#Sec9}
----------------------------------------------------------

The distribution of HCN channels in the olfactory bulb was examined with 12 different antibodies against the four HCN channel isoforms (Table [1](#Tab1){ref-type="table"}). Each HCN isoform was recognized by three antibodies generated in different species. In addition, for each HCN isoform, two antibodies were generated against different epitopes. The specificity and suitability of antibodies was ensured by three criteria. (1) Western blots of proteins from olfactory bulb and from HEK 293 cells that expressed either one of the four HCN isoforms. After treatment with PNGaseF to remove protein glycosylation, the antibodies recognized proteins of the expected molecular weight of 102, 94, 86, and 130 kDa for HCN1, HCN2, HCN3, and HCN4, respectively (Fig. [1](#Fig1){ref-type="fig"}a; Müller et al. [@CR46]). (2) Independent antibodies directed against the same HCN isoform produced identical staining patterns as demonstrated by the superposition of images (Fig. [1](#Fig1){ref-type="fig"}b, c, Electronic Supplementary Material, Fig. [1](#MOESM2){ref-type=""}). (3) In HCN1 and HCN3 knockout animals, no staining was observed with antibodies against the deleted isoform (Electronic Supplementary Material, Fig. [2](#MOESM4){ref-type=""}; HCN1 knockout mice: Nolan et al. [@CR47]; HCN3 knockout mice: gift of Martin Biel, Ludwig-Maximilians Universität, Munich, Germany). Fig. 1Survey of HCN channel expression in the olfactory bulb. **a** Antibodies against HCN1--HCN4 (*HCN1* RTQ-7C3, *HCN2* HCN2α, *HCN3* HCN3 Shigemoto, *HCN4* HCN4γ) recognize the glycosylated and degylcosylated HCN isoforms in Western blots of proteins from mouse olfactory bulb. The enzyme PNGaseF was used to deglycosylate HCN channels (*+ lanes*). Molecular weights of deglycosylated HCN channels were 102 kDa (HCN1), 94 kDa (HCN2), 86 kDa (HCN3), and 130 kDa (HCN4). Comparison of molecular weights with (*+ lanes*) and without (*− lanes*) PNGaseF treatment shows that all HCN isoforms are glycosylated (*numbers right* molecular weight markers in kDa). **b**, **c** Representative example of double-labeling with two antibodies (**b** QQA-1A6, **c** HCN2α) that recognize different epitopes of one and the same HCN isoform (HCN2). The staining patterns produced by the two antibodies are identical. Field of view reaches from the glomerular layer (*top*) to the external plexiform layer (*bottom*). *Bar* 20 μm. **d--g** Immunohistochemical staining shows the distribution of HCN1 (**d**), HCN2 (**e**), HCN3 (**f**), and HCN4 (**e**) within the various layers of the olfactory bulb in 20-μm-thick coronal sections (*EPL* external plexiform layer, *GL* glomerular layer, *GrL* granule cell layer, *IPL* internal plexiform layer, *ML* mitral cell layer, *AL* olfactory nerve layer). Antibodies used were: HCN1α (**d**), QQA-1A6 (**e**), HCN3α4 (**f**), PG2-1A4 (**g**). *Bar* 100 μm

Each HCN isoform showed a characteristic expression pattern in the various layers of the olfactory bulb (Fig. [1](#Fig1){ref-type="fig"}c, e--g). The HCN staining originated from somata and neuronal processes alike. Each HCN isoform was found only in subsets of cells. Therefore, staining intensities differed between different layers. HCN1 was strongly expressed in the glomerular layer (GL), followed by some weaker expression in the internal plexiform layer (IPL) and the granule cell layer (GrL). Only weak staining was observed in the external plexiform layer (EPL). For HCN2, the most intense staining was observed in individual cell bodies distributed across all but the olfactory nerve layer (AL). HCN3 was strongly expressed in the IPL and the outer part of the EPL. Strong HCN4 staining was observed in all layers; in the AL, it appeared to be the only HCN isoform. Thus, in the GL, abundant expression of all four HCN isoforms was observed. In the following, we restrict our analysis to the GL.

HCN isoforms are expressed in many different combinations {#Sec10}
---------------------------------------------------------

In the GL, antibodies against all HCN isoforms stained the somatic and dendritic plasma membrane (Fig. [2](#Fig2){ref-type="fig"}). Moreover, the specific glia cell marker GFAP (glial fibrillary acidic protein) did not co-localize with HCN staining, suggesting that the majority of HCN channels were present in neurons (Electronic Supplementary Material, Fig. [6](#MOESM12){ref-type=""}). Cells stained by HCN antibodies fell into two groups. The first group was characterized by relatively small somata and thin dendritic processes (Fig. [2](#Fig2){ref-type="fig"}e--o). This group comprised both PG and SA cells. The second group displayed large somata and usually possessed only one thick primary tuft, which ramified within a single glomerulus, features characteristic of ET cells (Fig. [2](#Fig2){ref-type="fig"}p--s, see also [Materials and methods](#Sec2){ref-type="sec"}). Fig. 2Localization pattern of HCN channel isoforms in the glomerular layer. **a--d** Low magnification of triple-labeling for HCN1 (*green*, RTQ-7C3), HCN3 (*red*, HCN3 Shigemoto), and HCN4 (*blue*, PG2-1A4) in the external plexiform layer (*EPL*) and glomerular layer (*GL*). **e--o** Example of various populations of PG- and SA-like cells. Three cell populations express only a single HCN isoform (*overlays* in **h**, **k**, **o**: *green arrowhead* HCN1, *blue barred arrow* HCN2, *dark blue arrowhead* HCN4). This is demonstrated with triple-labeling (**e--h**) for HCN1 (*green* HCN1α), HCN2 (*blue* HCN2α), and HCN4 (*red* PG2-1A4), double-labeling (**i--k**) for HCN2 (*green* QQA-1A6) and HCN3 (*red* HCN3 Shigemoto), and triple-labeling (**l--o**) for HCN1 (*green* HCN1α), HCN3 (*red* HCN3α4), and HCN4 (*blue* PG2-1A4). The cell population expressing only HCN4 is also visible in **s** (*dark blue arrowheads*). Co-localization of either HCN1 (*green* HCN1α) and HCN3 (*red* HCN3 Shigemoto) or HCN1 (*green* HCN1α) and HCN4 (*blue* PG2-1A4) in two additional cell populations (*orange arrowhead*, *red arrowhead*, respectively) is shown in **o**. **p--s** Three ET-like cell populations with different repertoires of HCN isoforms (*white arrow* HCN1, HCN3, and HCN4, *orange arrow* HCN1 and HCN3, *purple arrow* HCN3 and HCN4) can be detected in the triple-staining for HCN1 (*green* HCN1α), HCN3 (*red* HCN3 Shigemoto), and HCN4 (*blue* PG2-1A4). PG-like cells expressing only HCN4 are indicated (*dark blue arrowheads*). From these stainings, it is not apparent which of the cell populations identified in later experiments (Figs. [3](#Fig3){ref-type="fig"}, [4](#Fig4){ref-type="fig"}, [5](#Fig5){ref-type="fig"}) are stained. However, by using the results of all staining performed, one can unequivocally identify the cell types here. For convenience, cell populations in this and the following figures are labeled with the uniform color and arrow code shown in Table [2](#Tab2){ref-type="table"}. Glomeruli are indicated by an *asterisk* and delineated by a *dashed white line*. *Bars* 50 μm (**d**), 10 μm (**h**, **k**, **o**, **s**)

Triple- and double-labeling revealed subpopulations of PG- and SA-like cells that expressed either a single HCN isoform or combinations of HCN isoforms (Fig. [2](#Fig2){ref-type="fig"}e--s). Because compelling evidence (staining intensity of + or stronger in Table [2](#Tab2){ref-type="table"}) for the co-expression of HCN2 with the other isoforms was lacking (Fig. [2](#Fig2){ref-type="fig"}e--k), triple-staining with HCN1, HCN3, and HCN4 antibodies was sufficient to reconstruct a complete co-expression pattern of HCN channels (see Fig. [2](#Fig2){ref-type="fig"}l--s, Table [2](#Tab2){ref-type="table"}). PG- and SA-like cells were identified that expressed only HCN1 (Fig. [2](#Fig2){ref-type="fig"}l--o, green arrowheads) or HCN4 (Fig. [2](#Fig2){ref-type="fig"}p--s, dark blue arrowheads). Moreover, HCN1 and HCN3 co-localized (Fig. [2](#Fig2){ref-type="fig"}l--o, orange arrowhead) in one population of cells, and in another, HCN1 and HCN4 were co-localized (Fig. [2](#Fig2){ref-type="fig"}l--o, red arrowhead). Thus, some cell populations expressed a single HCN channel isoform only (HCN1, HCN2, or HCN4), whereas others co-expressed HCN1/3 or HCN1/4. Co-expression of HCN isoforms occurred more often in ET-like cells than in PG- and SA-like cells. The following combinations were observed: HCN1/3, HCN3/4, and HCN1/3/4 (Fig. [2](#Fig2){ref-type="fig"}a--d, p--s). This demonstrates, for the first time at the protein level, the expression of three HCN channel isoforms within the same neuron. Remarkably, in the GL, we could find no convincing evidence for the expression of HCN3 channels alone. Even in the entire main olfactory bulb, exclusive HCN3 staining was rarely observed (see Fig. [2](#Fig2){ref-type="fig"}a--d, outer EPL).

Staining patterns in somata and dendritic processes, e.g., the glomerular neuropil (region inside the dashed white outlines of glomeruli in Fig. [2](#Fig2){ref-type="fig"}), were similar. Dendrites harboring only HCN1, HCN2, or HCN4 were common, whereas dendrites expressing only HCN3 were rare. Furthermore, HCN2 by and large was expressed on its own. Co-localization of HCN1, HCN3, and HCN4 existed in all possible combinations (HCN1/3, HCN1/4, HCN3/4, and HCN1/3/4). Relatively thick dendritic processes in the outer EPL (Fig. [2](#Fig2){ref-type="fig"}a--d) showed the co-localization of either HCN3/4 (purple dendritic processes in Fig. [2](#Fig2){ref-type="fig"}d) or of HCN1/3/4 (white dendritic processes in Fig. [2](#Fig2){ref-type="fig"}d). By visual inspection of staining, we observed that the thick dendritic processes originated from the somata of ET-like cells and extended laterally into the EPL. Thus, they probably represented lateral dendrites of at least two different ET cell populations. One ET cell population expressed HCN3/4, whereas another population expressed HCN1/3/4.

The rich expression patterns of HCN channels indicate that many different cell populations exist. In the following, we relate HCN channel expression patterns to previously described cell populations by combining immunostaining for markers and HCN.

Immunohistochemical characterization of juxtaglomerular cells expressing HCN channels {#Sec11}
-------------------------------------------------------------------------------------

We used antibodies against eight cellular marker proteins to characterize populations of juxtaglomerular cells expressing HCN channels. Seven of these marker proteins, including tyrosine hydroxylase (TH), nitric oxide synthase (NOS), the neuropeptide cholecystokinin (CCK), the calcium-binding proteins visinin-like protein 1 (vilip1; also known as neurocalcin α), parvalbumin (PV), calretinin (CR), and calbindin-D28K (CB), have been previously used to distinguish between subpopulations of juxtaglomerular cells (Baker et al. [@CR6]; Brinon et al. [@CR13], [@CR14], [@CR15]; Kosaka et al. [@CR32]; Liu and Shipley [@CR36]; Bastianelli and Pochet [@CR8]; Crespo et al. [@CR18]; Bernstein et al. [@CR11]; Gutierrez-Mecinas et al. [@CR24]; Parrish-Aungst et al. [@CR51]; Kosaka and Kosaka [@CR31]). In general, the staining patterns that we obtained for these marker proteins were similar to those published. In addition, we employed antibodies against hippocalcin, another calcium-binding protein, which proved useful as another marker to distinguish between different juxtaglomerular cells. To the best of our knowledge, hippocalcin antibodies have not been used before for staining of the olfactory bulb. A lower magnification of a representative hippocalcin staining is shown in Electronic Supplementary Material, Fig. [3](#MOESM6){ref-type=""}. We used marker and HCN channel antibodies in more than 140 combinations. We found highly reproducible co-localization patterns in the different juxtaglomerular cell populations (for details see [Electronic Supplementary Material](#AppESM1){ref-type="sec"}); these patterns are referred to as IFs in the following.

In many cases, marker antibodies stained cells intensely, thereby revealing even small anatomical details that allowed us to distinguish between populations of PG and SA cells. PG cells are neurons with small somata and usually have one to two dendrites that ramify extensively in a single (sometimes two) neighboring glomeruli. In contrast, SA cells are larger than most PG cells. Often, SA cells have more than two dendrites, which do not ramify in glomeruli (Table [3](#Tab3){ref-type="table"}) but rather reach across several adjacent glomeruli to contact other juxtaglomerular cells (Pinching and Powell [@CR53]).

**PG-like cells** In PG-like cells, at least nine different IFs were identified (IF1--IF9) that showed multiple expression patterns of HCN channels (Fig. [3](#Fig3){ref-type="fig"}, Table [2](#Tab2){ref-type="table"}, Electronic Supplementary Material, Fig. [4](#MOESM8){ref-type=""}). In two IFs, strong staining for one HCN isoform was present (IF1 and IF2). In four other IFs, moderate staining for either one HCN isoform (IF6) or several HCN isoforms was observed (IF3--IF5), and the remaining IFs seemed to be devoid of HCN staining (IF7--IF9). A detailed description of IFs found in PG-like cells is given in the [Electronic Supplementary Material](#AppESM1){ref-type="sec"}. Fig. 3Antibody staining in PG-like cell populations. **a--d** Example of marker staining (*green* CR, *red* NOS, *blue* vilip1), which partially overlaps in PG-like cells (*arrowheads*). Antibodies used were: CAL, NOSmono, and vilip1. **e--h** Different co-localizations of HCN isoforms (*green* HCN1, *red* HCN4) and marker staining (*blue* CB) in PG-like cells (*arrowheads*). Antibodies used were: HCN1α, PG2-1A4, and CabPneu. Further staining is shown in Electronic Supplementary Material, Fig. [4](#MOESM8){ref-type=""}. All staining patterns are summarized in Table [2](#Tab2){ref-type="table"}. Color codes of *arrowheads* as in Table [2](#Tab2){ref-type="table"}. *Bars* 10 μm

**SA-like cells** Two IFs were identified in SA-like cell populations (IF10 and IF11). We found strong HCN staining in both IFs. Strong staining for NOS and HCN3, but weak staining for HCN4 was detected in IF10 (Fig. [4](#Fig4){ref-type="fig"}b--h, Table [2](#Tab2){ref-type="table"}). Dendrites of cells with the IF10 usually reached across several adjacent glomeruli (Fig. [4](#Fig4){ref-type="fig"}a). Fig. 4Antibody staining in two SA-like cell populations. **a--h** Immunohistochemical identification of SA-like cells with IF10. Cells with IF10 (*green barred arrow*) are characterized by the co-localization of HCN1, HCN3, HCN4, and NOS. **a** A cell with IF10 is labeled by antibodies directed against NOS (NOSpoly). A long (\>100 μm) dendrite is visible. **b--e** Triple-staining for HCN1 (*blue* HCN1α), NOS (*green* NOSpoly), and HCN4 (*red* PG2-1A4). Cells with IF10 show strong expression of NOS, weaker expression of HCN4, and expression around the detection threshold of HCN1. **f--h** Double-staining for NOS (*green* NOSpoly) and HCN3 (*red* HCN3 Shigemoto). **i--k** Immunohistochemical identification of cells with IF11 (*blue barred arrow*). These cells express HCN2 (*red* QQA-1A6). Projection of a confocal LSM section series reveals that dendrites of cells with IF11 do not reach into glomeruli. Glomeruli are visible because of the ramification of vilip1-stained PG-like cells (*green* vilip1) within glomeruli. Color codes of *barred arrows* as in Table [2](#Tab2){ref-type="table"}. *Bars* 10 μm (**e**, **h**, **k**), 50 μm (**a**) IF11 (labeling with HCN2 antibodies only) was found in a second SA-like cell population. The cell type could not be classified unequivocally, because distal dendrites were not stained (independent observers classified these cells as PG-like or SA-like). Based on the soma size alone, these cells might represent SA cells or large PG cells (for a comparison, see Table [3](#Tab3){ref-type="table"}). However, whereas PG cells usually had one or two dendrites that ramified within glomeruli, cells with IF11 had more than three dendrites that could not be traced into glomeruli but rather seemed to surround them (Fig. [4](#Fig4){ref-type="fig"}i--k). Therefore, we suggest classifying these cells as SA-like cells. A detailed description of IFs found in SA-like cells is given in the [Electronic Supplementary Material](#AppESM1){ref-type="sec"}.We observed TH-positive cells at the border to the EPL; these probably corresponded to SA cells recognized previously (Kosaka et al. [@CR33]). Within the GL, these cells could not be distinguished unequivocally from the large number of TH-expressing juxtaglomerular cells and, therefore, were not further analyzed.

**ET-like cells** Six different IFs were identified in ET-like cells (Fig. [5](#Fig5){ref-type="fig"}, Electronic Supplementary Material, Fig. [5](#MOESM10){ref-type=""}). IF12--IF15 represented different combinations of staining for HCN isoforms, whereas IF16 and IF17 were virtually devoid of HCN channel staining. IF12--IF15 contained staining for CCK but differed in their staining for HCN1, HCN4, NOS, vilip1, and hippo (Table [2](#Tab2){ref-type="table"}, Fig. [5](#Fig5){ref-type="fig"}a--d, Electronic Supplementary Material, Fig. [5](#MOESM10){ref-type=""}). IF12 featured staining with HCN1, HCN3, and HCN4 antibodies. In IF13 and IF15, HCN3 was found together with HCN4, whereas in IF14, HCN3 was present with HCN1 (Electronic Supplementary Material, Fig. [5](#MOESM10){ref-type=""}). Cells with IF12, IF13, and IF15 possessed lateral dendrites (Table [3](#Tab3){ref-type="table"}). Fig. 5Antibody staining in ET-like cell populations within the GL. **a--d** Example of ET-like cells (*arrows*) expressing HCN1 channels (*green* HCN1α) and CCK (*red* CCK). Some of the HCN1- and CCK-expressing cells (*orange arrows*) are also immunostained by antibodies directed against vilip1 (*blue* vilip1). **e--l** All TH-positive (*green*) ET-like cells (*arrows*) express hippo (*red*). Two representative examples are shown (**e--h**, **i--l**). TH-positive ET-like cells are either faintly stained (**g**) by NOS antibodies (*blue*) or devoid of NOS staining (**k**). Note the pronounced thick primary tuft in the ET-like cells. Antibodies used in **e--l** were: hippo, NOSgt, and TH. Further staining is shown in Electronic Supplementary Material, Fig. [5](#MOESM10){ref-type=""}. All staining patterns are summarized in Table [2](#Tab2){ref-type="table"}. Color codes of *arrows* as in Table [2](#Tab2){ref-type="table"}. *Bars* 10 μmIF16 and IF17 featured staining with antibodies directed against TH (Fig. [5](#Fig5){ref-type="fig"}e--l). Co-localization of CCK and TH was never observed. IF16 contained NOS staining, whereas IF17 was devoid of it. No lateral dendrites were identified in cells with TH staining. A detailed description of IFs found in ET-like cells is given in the [Electronic Supplementary Material](#AppESM1){ref-type="sec"}.

**Summary** The combination of classical markers and HCN channel antibodies allowed us to identify cell populations that show one of at least 17 IFs. Four cell populations expressed only a single HCN isoform, two cell populations were stained by HCN antibodies only, six cell populations co-expressed several HCN channel isoforms, and five cell populations lacked HCN channels.

Frequency and soma size of populations of juxtaglomerular cells {#Sec12}
---------------------------------------------------------------

For a full characterization of the immunohistochemically different cell populations in the GL, we estimated their frequency per glomerulus (see [Materials and methods](#Sec2){ref-type="sec"}) and related it to the total number of cells per glomerulus as visualized by TOPRO-3, a dye that intercalates into the DNA of all cells (Table [3](#Tab3){ref-type="table"}).

We counted cells across 81 adjacent glomeruli in three animals and estimated a total of 705±136 cells per glomerulus, in good agreement with an analysis by Parrish-Aungst et al. ([@CR51]) who recorded ∼680 cells per glomerulus. On average, 40% of cells in the GL were PG cells (267±25 cells per glomerulus), as determined by counting cells across at least 121 adjacent glomeruli per PG-like cell population in at least three animals (see [Materials and methods](#Sec2){ref-type="sec"}). SA-like cells and ET-like cells represented only 1% and 5% of cells, respectively: 9±1 SA-like cells per glomerulus (≥343 adjacent glomeruli in ≥3 animals per cell population), and 32±6 ET-like cells per glomerulus (≥138 adjacent glomeruli in ≥3 animals per cell population).

The estimate critically depended on whether all juxtaglomerular cell populations were identified. To estimate the fraction of juxtaglomerular cells that escaped staining, we compared, in the same section, the number of immunohistochemically labeled cells with the number of TOPRO-3-stained cells. The combination of antibodies directed against TH, NOS, CB, vilip1, CR, HCN1, HCN2, and HCN4 was sufficient to stain all juxtaglomerular cell populations identified in this study (see Table [2](#Tab2){ref-type="table"}). GFAP staining was used to distinguish glia cells from neurons. The majority of glia cells in the GL are GFAP-positive astrocytes (Bailey and Shipley [@CR5]; Kimelberg [@CR29]). None of the staining for markers or HCN channels co-localized with the GFAP staining.

If many antibodies are combined and visualized by using secondary antibodies conjugated to the same dye, the equivalent detection of strong and weak staining is difficult. Thus, weakly stained cells may escape detection. To circumvent this problem, we visualized strongly and weakly staining antibodies with different dyes and adjusted detection settings to match the staining intensity. In combined TOPRO-3 and antibody staining (Fig. [6](#Fig6){ref-type="fig"}), we counted cells across 51 adjacent glomeruli (two animals) and identified 2.9% cells not labeled by the antibody mixture. The majority of these cells (2%) were positioned at the border to the AL or EPL, probably representing cells of the AL and EPL rather than those of the GL. The few cells in the GL not labeled by antibodies (0.9%) may have represented GFAP-negative glia cells (Kimelberg [@CR29]). When one of the nine antibodies was omitted, the number of unstained cells was significantly enhanced (data not shown). Together, these results demonstrate that the vast majority, possibly even all, of the juxtaglomerular cells have been stained by our markers. Fig. 6Do our antibodies label all populations of juxtaglomerular cells? Practically all juxtaglomerular cells have been stained with at least one of the antibodies against (**a**) markers (*green* TH, NOS, CB, vilip1, CR, GFAP) or (**b**) HCN channels (*red* HCN1, HCN2, HCN4). **c** Nuclei are stained by TOPRO-3 (*blue*). **d** Overlay of **a--c**. Confocal LSM sections rarely show unstained cells (*arrows*). Note: most unstained cells are positioned at the borders of the GL. Antibodies used: TH, CabPneu, NOSpoly, vilip1, CAL, PG2-1A4, QQA-1A6, HCN1α, and GFAP (*EPL* external plexiform layer, *GL* glomerular layer, *AL* olfactory nerve layer). *Bar* 10 μm

Populations of juxtaglomerular cells not only differed in IFs, but also in their morphology. Significant differences in the soma size of populations of PG-like cells were apparent, in agreement with previous reports (e.g., Kosaka and Kosaka [@CR31]; Parrish-Aungst et al. [@CR51]; Pinching and Powell [@CR53]; Qin et al. [@CR55]).

To quantify the soma size, we determined the apparent cell diameter from the measured circumference (Table [3](#Tab3){ref-type="table"}). Mean diameters of PG-like cells (IF1-IF9) were between 6.5 μm and 9.1 μm; most diameters were ca. 8 μm. By pair-wise Kruskal-Wallis tests with all possible combinations of mean diameters, we observed that most diameters of these PG-like cells were statistically different from those of other PG-, SA-, and ET-like cells: 94 of 108 possible pair-wise combinations between different PG-like cells, PG-like and SA-like cells, and PG-like and ET-like cells had a *P*-value well below 0.001. However, cells with the IF7 and IF8 (*P*=0.98) and cells with the IF2, IF6, and IF9 (*P*\>0.76) had similar diameters. The soma diameters of the two SA-like populations were similar (cells with IF10: 9.4±1.1 μm; cells with IF11: 8.9±0.7 μm), although this difference was statistically significant (*P*=0.035). ET-like cells had soma diameters ranging from 11.6 μm to 12.6 μm. Pair-wise comparisons of cells with IF12/IF17 and IF13/IF16 showed similar diameters (*P*\>0.76). Cells with IF14 and IF16 differed in their somatic diameters (*P*\<0.02); all other possible comparisons of ET-like cell diameters were neither statistically different nor statistically similar (0.1\<*P*\<0.65). Soma diameters resembled the diameters of PG, SA, and ET cells as described in classical Golgi-impregnated studies (Pinching and Powell [@CR53]).

Discussion {#Sec13}
==========

HCN channels in juxtaglomerular cells {#Sec14}
-------------------------------------

Using a comprehensive set of antibodies, including antibodies against all four HCN channel isoforms, we have conducted a systematic analysis of the glomerular layer. All four HCN isoforms are abundantly expressed in the olfactory bulb of mice. Many different combinations of HCN isoform co-localization in juxtaglomerular cells have been found. In our attempt to relate HCN channel expression patterns to previously described cell types, we have identified at least 17 IFs. In twelve of these IF, we have detected HCN channels. Two cell populations have probably been identified for the first time, because they are stained by HCN antibodies, but not by other markers (IF2 and IF11).

In some IFs, the intensity of marker and HCN stainings appears to be variable. This might reflect the presence of more than 17 cell populations. For example, evidence exists that IF7, IF8, and IF9 can be divided further on the basis of the differential expression of glutamic acid decarboxylase 65 (GAD65) and GAD67 in both TH- and CR-expressing cell types (Parrish-Aungst et al. [@CR51]). In addition, activity-dependent up- or down-regulation of expression levels could result in variable staining intensities. This has been suggested for TH- and NOS-expressing cell types (Brinon et al. [@CR16]; Weruaga et al. [@CR66]). Finally, regeneration of neurons is a prominent feature of the adult olfactory bulb. In the GL, PG cells that express TH, CR, CB, or vilip1 have been shown to be constantly renewed (De Marchis et al. [@CR20]). During maturation, these cells may express proteins at different levels; thus, the staining variability in some cell populations may result from the difference between developing and mature cells. However, for the following reasons, we favor the possibility that most IFs reflect the presence of different cell types, rather than only a few cell types with different levels of activity and/or different states of maturation: (1) marker staining and marker co-localization are highly reproducible, (2) the staining intensity for many markers does not show a large degree of variability but can be considered almost all-or-none, (3) none of the IFs appear to be clustered around individual, possibly activated glomeruli but are homogenously distributed among glomeruli.

Most of the previous studies of the olfactory bulb have been performed in rat. However, an important animal model for olfactory research is the mouse. This work and a few other recent studies have shown that the expression patterns of HCN channels and marker proteins are similar in the mouse and rat (Kosaka and Kosaka [@CR31]; Panzanelli et al. [@CR50]; Parrish-Aungst et al. [@CR51]; Notomi and Shigemoto [@CR48]). For example, in mouse, HCN1 is strongly expressed in PG-like cells with IF1, which are positive for vilip1 and NOS, but negative for CR and TH. In rat, HCN1 is also found in PG cells that have not been tested for vilip1 or NOS but that are negative for CR and TH (Holderith et al. [@CR27]). On the other hand, our results demonstrate that HCN4 is strongly and abundantly expressed in the mouse. This has not been described in the rat by Notomi and Shigemoto ([@CR48]) and may either reflect differences between the mouse and rat, the improvement of HCN4 antibodies, or the optimized staining procedures used in our analysis.

Based on their synaptic connectivity, PG cells fall into two groups. Type I cells, but not type II cells, seem to receive direct excitatory input from ORNs. The two groups were originally established by electron microscopy and immunogold staining with common marker antibodies for PG cells. TH and CCK staining has been found in PG cells of type I (Gutierrez-Mecinas et al. [@CR24]; Kosaka et al. [@CR33]; Kosaka and Kosaka [@CR30]), and CR, CB, and HCN1 have been found in PG cells of type II (Holderith et al. [@CR27]; Kosaka et al. [@CR33]; Kosaka and Kosaka [@CR30]). According to the expression of TH, CCK, CR, CB, and HCN1, we can assign our PG populations to either type I or II. Cells with IF3, IF4, and IF9 belong to type I, whereas cells with IF1, IF5, IF6, IF7, and IF8 belong to type II. Because no commonly used marker stains cells with IF2, they have escaped classification so far. IF10--IF17 have been found in SA- and ET-like cells and cannot be classified as type I or II, because this division is exclusively defined for PG cells.

Approximately 700 cells surround a standard glomerulus: about 40% are PG cells, 1% are SA cells, and 5% are ET cells. The rest of the cells (54%) represent astrocytes, oligodendrocytes, microglia, and cells of the vasculature. We have not counted GFAP-positive astrocytes in the GL directly, because this is compromised by the location of GFAP in processes rather than in cell bodies (Bailey and Shipley [@CR5]). Here, we have stained the vast majority (possibly all) juxtaglomerular cell populations. Thus, the ratio of identified-to-unidentified cell types should represent the neuron-to-glia ratio. We have calculated, on the basis of "numbers of cells per section of a glomerulus" (see Table [3](#Tab3){ref-type="table"}), a ratio of 1.1±0.3 neurons-to-glia cells. Because our frequency estimates of neuron populations are expected to be lower limits (see [Materials and methods](#Sec2){ref-type="sec"}), the ratio of 1.1 is also expected to be a lower limit. The neuron-to-glia ratio in the GL is similar to the ratio in other layers of the brain (Roy et al. [@CR56]). A previous estimation of the olfactory bulb has given a ratio of about 1.7 (Parrish-Aungst et al. [@CR51]).

The frequencies of the cell populations reported here are similar to those described by other studies. For example, Panzanelli et al. ([@CR50]) have calculated that 44%, 16%, and 14% of PG cells are CR-, TH-, and CB-positive, respectively. We have observed 50%, 11%, and 11% of the respective PG cells. Parrish-Aungst et al. ([@CR51]) report that 10%, 27%, 10%, 0.4%, and 11% of juxtaglomerular neurons are stained by antibodies against CB, CR, vilip1, PV, and TH, respectively. We have observed 10%, 43%, 19%, 4%, and 13%. Differences between our and published frequencies are probably attributable to different immunohistochemical procedures. Differences in the immunohistochemical procedure have been reported to affect the staining intensity of some of the antibodies used here and, thereby, influence frequency calculations (Kosaka and Kosaka [@CR30]).

Functional implications of HCN channel expression {#Sec15}
-------------------------------------------------

An intriguing result is the prominent co-localization of HCN channel isoforms in juxtaglomerular cells. The co-expression of HCN isoforms is apparent in six of 17 identified fingerprints. If cases with +/− HCN staining intensity are included, co-expression is observed in 10 out of 17 identified fingerprints. Whether HCN channels form heteromeric complexes in vivo is still unknown. Although different HCN channel isoforms may co-localize without forming heteromers (Müller et al. [@CR46]), heteromerization has been suggested to give rise to the functional diversity of HCN channels (Chen et al. [@CR17]; Much et al. [@CR45]; Ulens and Tytgat [@CR62]). The composition and stoichiometry of HCN channel heteromers in neurons has rarely been analyzed (e.g., Whitaker et al. [@CR67]). Likewise, the properties or physiological function of heteromeric HCN channels is not well understood (Chen et al. [@CR17]; Ulens and Tytgat [@CR62]; Whitaker et al. [@CR67]). The large variety of expression patterns of HCN channels indicates the functional diversity of juxtaglomerular cells. For example, several juxtaglomerular cell types display intrinsic oscillatory activities (Antal et al. [@CR3]; Hayar et al. [@CR25], [@CR26]). Interestingly, all HCN-positive ET cell populations express more than one HCN isoform (IF12--IF15). Because about 60% of ET cells exhibit rhythmic bursts of action potentials (Antal et al. [@CR3]; Hayar et al. [@CR25], [@CR26]), and because cells with IF12--IF15 constitute about 70% of all ET cells, heteromeric HCN channels may be important for generating or modulating rhythmic activity. On the other hand, TH-expressing cells are also capable of generating rhythmic activity (Pignatelli et al. [@CR52]). We have been unable to detect HCN channels in these cell types (IF9, IF16, and IF17); therefore, HCN channels are not the only channels involved in the generation of intrinsic rhythmic activity in the GL. Indeed, persistent sodium currents have been implicated in the generation of oscillations (Hayar et al. [@CR25], [@CR26]; Pignatelli et al. [@CR52]).

Concluding remarks {#Sec16}
------------------

Our results suggest that HCN channels play a key role in neuronal activity, e.g., in rhythmical bursts of action potentials. Moreover, the different expression patterns of HCN channels suggest a strong functional diversity of cell populations. A challenge for future work will be to define precisely, in quantitative terms, the diverse function of homomeric and heteromeric HCN channels in the nervous system, to identify the properties and physiological functions of the diverse cell types, and to establish a model of the sophisticated information processing that occurs in the olfactory bulb by taking its cellular and functional diversity into account.
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Specificity of HCN staining in the GL revealed by double-labeling with antibodies recognizing different epitopes of HCN1 (**a--c**), HCN2 (**d--f**), HCN3 (**g--h**), and HCN4 (**j--l**), respectively. Antibodies (see Table [1](#Tab1){ref-type="table"}) are specified in each panel. In each of the double-labeling experiments, antibodies directed against the same HCN isoform yielded qualitatively identical staining patterns. This indicates specificity of antibodies with cross-reactivity below background levels. *Bars* 10 μm (GIF 302 kb)
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High resolution image file (TIFF 9036 kb)

###### 

Specificity of HCN1 and HCN3 antibodies revealed in knockout animals. **a**, **b** Representative staining with antibodies directed against HCN1 (HCN1α) in wild-type (**a**) and HCN1 knockout (**b**) animals. **c**, **d** Representative staining with antibodies directed against HCN3 (HCN3 Shigemoto) in wild-type (**c**) and HCN3 knockout (**d**) animals. No staining is observed in the knockout animals indicating specificity of antibodies with cross-reactivity below background levels. *Bars* 100 μm (GIF 42 kb)
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High resolution image file (TIFF 3116 kb)
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Staining with antibodies directed against hippocalcin (hippo) at low magnification. Hippo staining is found in several layers of the olfactory bulb (GL, EPL, IPL, and GrL). No staining is visible in the AL and ML (*EPL* external plexiform layer, *GL* glomerular layer, *GrL* granule cell layer, *IPL* internal plexiform layer, *ML* mitral cell layer, *AL* olfactory nerve layer). *Bars* 100 μm (GIF 111 kb)
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Immunohistochemical identification of PG-like cell populations. **a-a'''** Example of stained PG-like cells at low magnification. Triple-labeling for HCN1 (*green* HCN1α), HCN4 (*red* PG2-1A4), and CB (*blue* CabPneu) reveals IF1 (*green arrowhead* only HCN1-positive), IF2 (*dark blue arrowhead* only HCN4-positive), IF5 (*red arrowhead* HCN1-, HCN4-, and CB-positive), and IF6 (*light blue arrowhead* HCN4- and CB-positive). **b- and c-panels:** Immunohistochemical identification of cells with IF1. IF1 cells (green arrowhead) are characterized by the co-localization of HCN1, NOS, vilip1, and hippo as seen in two triple labelings (**b-b'''** HCN1 (*green*), NOS (*red*), and vilip1 (*blue*); antibodies used were: HCN1α, NOSmono, and vilip1. **c-c'''** HCN1 (*green*), NOS (*red*), and hippo (*blue*); antibodies used were: HCN1α, NOSmono, and hippo. **d-g'''** Immunohistochemical identification of cells with IF3 and IF4. Both IF3 (*pink arrowhead*) and IF4 (*orange arrowhead*) feature co-expression of HCN1, HCN3, CCK, and vilip1. The HCN1 staining is often just above background and therefore not clearly visible in all staining experiments. PV is only detectable in IF4. The co-localization patterns in IF3 and IF4 are shown in the following four triple-staining experiments. **d-d'''** HCN1 (*green*), CCK (*red*), and vilip1 (*blue*); antibodies used were: HCN1α, CCK, and vilip1. **e-e'''** CCK (*green*), HCN3 (*red*), and PV (*blue*); antibodies used were: CCK, HCN3 Shigemoto, and PV. **f-f'''** HCN1 (*green*), CCK (*red*), and PV (*blue*); antibodies used were: HCN1α, CCK, and PV. **g-g'''** HCN1 (*green*), HCN3 (*red*), and PV (*blue*); antibodies used were: HCN1α, HCN3 Shigemoto, and PV). **h-h'''** Immunohistochemical identification of cells with IF7 and IF8. Triple-labeling for CR (*green* CAL), NOS (*red* NOSmono), and vilip1 (*blue* vilip1) reveals IF7 (*black arrowhead* only CR-positive) and IF8 (*gray arrowhead* CR-, NOS-, and vilip1-positive). **i-i'''** Immunohistochemical identification of cells with IF5 and IF6. Triple-labeling for HCN1 (*green* HCN1α), hippo (*red* hippo), and CB (*blue* CabPneu) reveals IF5 (*red arrowhead* HCN1-, hippo-, and CB-positive) and PG6 (*light blue arrowhead* hippo- and CB-positive). Note that cells with IF5 and IF6 have also been characterized in **a-a'''**. **j-j''** Immunohistochemical identification of cells with IF9. Co-localization of TH (*green* TH) and hippo (*red* hippo) reveals IF9 (*white arrowhead*, TH- and hippo-positive). Color codes of *arrowheads* as in Table [2](#Tab2){ref-type="table"} (**a-a'''**, **h-h'''** also shown in Fig. [3](#Fig3){ref-type="fig"}). *Bars* 10 μm (GIF 422 kb)
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Immunohistochemical identification of ET-like cell populations. **a-h'''** Immunohistochemical identification of cells with IF12, IF13, IF14, and IF15. **a-a'''** Triple-staining for HCN1 (*green* HCN1α), CCK (*red* CCK), and NOS (*blue* NOSmono) reveals four different CCK-positive IFs in ET-like cells. IF12 (*white arrows*): strong co-expression of HCN1, CCK, and NOS. IF13 (*purple arrow*): co-expression of CCK and NOS, with little or no HCN1. IF14 (*brown arrow*): co-expression of HCN1, and CCK, and only weakly NOS. IF15 (*lilac arrow*): only CCK expression. **b-b'''** Triple-staining for HCN1 (*green* HCN1α), HCN3 (*red* HCN3 Shigemoto), and NOS (*blue* NOSpoly) shows the expression of HCN3 in cells with IF14 (*brown arrow*; identified by moderate HCN1 and weak NOS staining). Weak HCN3 expression is also seen in cells with IF13 (*purple arrow*; identified by strong NOS and no HCN1). **c-c'''** Triple-staining for HCN1 (*green* HCN1α), HCN3 (*red* HCN3 Shigemoto), and vilip1 (*blue* vilip1) shows strong expression of vilip1 in cells with IF14 (HCN1- \[*green*\] and HCN3- \[*red*\]) positive) and weak expression of vilip1 in cells with IF12 (also HCN1- \[*green*\] and HCN3- \[*red*\] positive). The strong vilip1 expression in weakly NOS-positive cells (IF14) was confirmed by vilip1 and NOS double-staining (data not shown). **d-d'''** For the staining for HCN1 (*green* HCN1α), CCK (*red* CCK), and vilip1 (*blue* vilip1), the sensitivity of the detector for vilip1 was adjusted to match the strong staining in IF14 (*brown arrow*; note the pronounced dendritic tuft in the ET-like cells shown here). Expression of vilip1 in cells with IF12 is much weaker and, therefore, not visible at this detector setting. **e-e'''** Triple-staining for HCN1 (*green* HCN1α), HCN4 (*red* PG2-1A4), and NOS (*blue* NOSpoly) shows that HCN4 is found in IF12 (*white arrow*; HCN1 and strong NOS expression) and IF13 (*purple arrow*; strong NOS and no HCN1 expression), but not in IF14 (*brown arrow*; weak NOS and strong HCN1 expression). **f-f'''** Staining with four primary antibodies, viz., HCN4 (*green* PG2-1A4), HCN3 and NOS (*red* for HCN3 Shigemoto and for NOSpoly), and TH (*blue* TH). Although the same secondary antibody is used, because of the difference in subcellular localization, NOS (cytoplasmic staining) and HCN3 (plasma membrane staining) can be clearly differentiated. HCN3 and HCN4 are co-expressed in cells with IF15 (*lilac arrow*). **g-g'''** Triple-staining for HCN1 (*green* HCN1α), HCN4 (*red* PG2-1A4), and hippo (*blue* hippo). Hippo is present in IF14 (*brown arrow*; strong HCN1 and no HCN4 expression). **h-h'''** Triple-staining for HCN1 (*green* HCN1α), CCK (*red* CCK), and hippo (*blue* hippo). Expression of hippo is found in a cell positive for CCK but negative for HCN1, a feature characteristic either for IF13 or, in this case, for IF15 (*lilac arrow*). Because hippo is not found in strongly NOS-positive ET cells (i.e., IF13), the expression pattern of the cell (CCK and hippo, but no HCN1) is consistent with IF15 (data not shown). The second CCK-positive but HCN1-negative cell in this image (*purple arrow* IF13) is negative for hippo. **i-j'''** Immunohistochemical identification of cells with IF16 and IF17. IF16 and IF17 are positive for TH and hippo (*blue arrow* IF16, *gray arrow* IF17). **i--i'''** Triple-staining for TH (*green* TH), hippo (*red* hippo), and NOS (*blue* NOSgt) shows that all three markers are found in IF16 (*blue arrow* in **i'''**). **j-j'''** In a triple-staining with the same set of antibodies, IF17 is positive for TH and hippo but negative for NOS. Color codes of *arrows* as in Table [2](#Tab2){ref-type="table"} (**d-d'''**, **i-i'''**, **j-j'''** also shown in Fig. [5](#Fig5){ref-type="fig"}). *Bars* 10 μm (GIF 375 kb)
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Double-staining with antibodies directed against GFAP (*green*) and HCN channels (*red*) showing that no HCN staining is colocalized with GFAP. Thus, the majority of HCN1 (**a**), HCN2 (**b**), HCN3 (**c**), and HCN4 (**d**) channels are found in neurons rather then astrocytes. Antibodies used were: GFAP and HCN1α (**a**), GFAP and QQA-1A6 (**b**), GFAP and HCN3α4 (**c**), and GFAPab and PG2-1A4 (**d**). Note the HCN3-positive cells (*arrows* in **c**). *Bar* 100 μm (GIF 336 kb)
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Three-dimensional reconstructions of confocal z-stacks. **a** Reconstructions of two CB-positive (CabPneu) PG-like cells (*arrowheads*) with one or two dendrites that ramify within the same glomerulus. **b** Reconstruction of a NOS-positive (NOSpoly) SA-like cell (*arrow*) with a long dendrite. Three other cells (*stars*) lie in the direct vicinity of the SA-like cell body or dendrite and have not been perfectly reconstructed as separate objects. **c** Reconstruction of three vilip1-positive PG-like cells (*arrowheads*) with several dendrites, and an ET-like cell (*arrow*) with a thick primary tuft. **d** Reconstruction of a NOS-positive (NOSpoly) ET-like cell (*arrow*) with a thick primary tuft (*single star*) and a thick lateral dendrite (*double star*). *Bars* 10 μm (GIF 148 kb)
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High resolution image file (TIFF 7597 kb)
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